The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from ...

Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the ...

Nebula Next debuts the 01 Concept at CES, revealing a bold vision for luxury electric performance, design, and next-gen EV ...

For at least a decade, the quadruple axel jump was figure skating’s white whale. “It’s been this unreachable thing, like the ...

For at least a decade, the quadruple axel jump was figure skating’s white whale. “It’s been this unreachable thing, like the four-minute mile” once was, says Matthew Lind, a technical specialist for U ...

Roche’s phase III FENtrepid study of fenebrutinib meets its primary endpoint of non-inferiority compared to Ocrevus in reducing disability progression in patients with PPMS ...

Cell and gene therapy company ENCell said on the 6th that its allogeneic umbilical cord-derived mesenchymal stem cell therapy candidate "EN001" received orphan drug designation (ODD) from the U.S.

The octopus-inspired material could lead to better camouflage technology for the military and beyond.

Over the next two years, the planned funding will be allocated to projects that have received some FDA feedback as well as emerging efforts.

Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L demonstrated clinically meaningful efficacy ...

The UAE is rapidly consolidating its position as a global pharmaceutical and life sciences hub, with the national market ...

Santa Monica, California Monday, February 9, 2026, 12:00 Hrs [IST] ...